KR20010081369A - Slimming green tea and method for preparation thereof - Google Patents
Slimming green tea and method for preparation thereof Download PDFInfo
- Publication number
- KR20010081369A KR20010081369A KR1020000006766A KR20000006766A KR20010081369A KR 20010081369 A KR20010081369 A KR 20010081369A KR 1020000006766 A KR1020000006766 A KR 1020000006766A KR 20000006766 A KR20000006766 A KR 20000006766A KR 20010081369 A KR20010081369 A KR 20010081369A
- Authority
- KR
- South Korea
- Prior art keywords
- obesity
- green tea
- weight
- tea
- parts
- Prior art date
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 184
- 235000009569 green tea Nutrition 0.000 title claims abstract description 105
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title description 7
- 235000013616 tea Nutrition 0.000 claims abstract description 86
- 208000008589 Obesity Diseases 0.000 claims abstract description 61
- 235000021329 brown rice Nutrition 0.000 claims abstract description 54
- 235000020824 obesity Nutrition 0.000 claims abstract description 54
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 238000010025 steaming Methods 0.000 claims abstract description 18
- 240000008042 Zea mays Species 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 10
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 4
- 230000003579 anti-obesity Effects 0.000 claims description 69
- 239000000843 powder Substances 0.000 claims description 57
- 241000411851 herbal medicine Species 0.000 claims description 48
- 230000002401 inhibitory effect Effects 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 238000000605 extraction Methods 0.000 claims description 31
- 239000003814 drug Substances 0.000 claims description 25
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 235000008216 herbs Nutrition 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 15
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 15
- 235000005822 corn Nutrition 0.000 claims description 15
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 13
- 241000283690 Bos taurus Species 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000002023 wood Substances 0.000 claims description 8
- 239000003205 fragrance Substances 0.000 claims description 7
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 5
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 5
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 5
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 5
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 5
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 5
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 5
- 240000000171 Crataegus monogyna Species 0.000 claims description 5
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 5
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 5
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 241000238424 Crustacea Species 0.000 claims description 4
- 238000009395 breeding Methods 0.000 claims description 4
- 230000001488 breeding effect Effects 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- 244000299790 Rheum rhabarbarum Species 0.000 claims 3
- 235000013599 spices Nutrition 0.000 abstract description 3
- 239000006049 herbal material Substances 0.000 abstract 4
- 235000013291 Alisma plantago aquatica Nutrition 0.000 abstract 1
- 240000004615 Alisma plantago-aquatica Species 0.000 abstract 1
- 244000201986 Cassia tora Species 0.000 abstract 1
- 235000014552 Cassia tora Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000004659 Picrasma quassioides Species 0.000 abstract 1
- 235000010913 Picrasma quassioides Nutrition 0.000 abstract 1
- 241000205407 Polygonum Species 0.000 abstract 1
- 240000001745 Rheum palmatum Species 0.000 abstract 1
- 235000008090 Rheum palmatum Nutrition 0.000 abstract 1
- 235000007244 Zea mays Nutrition 0.000 abstract 1
- 229940089639 cornsilk Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940094952 green tea extract Drugs 0.000 abstract 1
- 235000020688 green tea extract Nutrition 0.000 abstract 1
- 235000008935 nutritious Nutrition 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 239000001231 zea mays silk Substances 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 34
- 235000009200 high fat diet Nutrition 0.000 description 25
- 230000000694 effects Effects 0.000 description 24
- 239000000047 product Substances 0.000 description 22
- 235000013361 beverage Nutrition 0.000 description 20
- 235000019197 fats Nutrition 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 17
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 238000009825 accumulation Methods 0.000 description 16
- 210000000577 adipose tissue Anatomy 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 14
- 235000019629 palatability Nutrition 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 12
- 206010020772 Hypertension Diseases 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- 241000219061 Rheum Species 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 10
- 235000005487 catechin Nutrition 0.000 description 10
- 230000035622 drinking Effects 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 238000005265 energy consumption Methods 0.000 description 9
- 238000002386 leaching Methods 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 7
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 229960001948 caffeine Drugs 0.000 description 7
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 7
- 235000019225 fermented tea Nutrition 0.000 description 7
- 235000019264 food flavour enhancer Nutrition 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000021590 normal diet Nutrition 0.000 description 6
- 230000035943 smell Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 5
- 241000018646 Pinus brutia Species 0.000 description 5
- 235000011613 Pinus brutia Nutrition 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 235000019577 caloric intake Nutrition 0.000 description 5
- 150000001765 catechin Chemical class 0.000 description 5
- 229950001002 cianidanol Drugs 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 235000006109 methionine Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001164 bioregulatory effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 208000026758 coronary atherosclerosis Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000020542 functional tea Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- FIHZWZBEAXASKA-UHFFFAOYSA-N Anthron Natural products COc1cc2Cc3cc(C)cc(O)c3C(=O)c2c(O)c1C=CC(C)C FIHZWZBEAXASKA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010021024 Hypolipidaemia Diseases 0.000 description 1
- 208000015580 Increased body weight Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 229930186851 sennoside Natural products 0.000 description 1
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- BPJYAXCTOHRFDQ-UHFFFAOYSA-L tetracopper;2,4,6-trioxido-1,3,5,2,4,6-trioxatriarsinane;diacetate Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].CC([O-])=O.CC([O-])=O.[O-][As]1O[As]([O-])O[As]([O-])O1.[O-][As]1O[As]([O-])O[As]([O-])O1 BPJYAXCTOHRFDQ-UHFFFAOYSA-L 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000021076 total caloric intake Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/12—Rolling or shredding tea leaves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/40—Tea flavour; Tea oil; Flavouring of tea or tea extract
- A23F3/405—Flavouring with flavours other than natural tea flavour or tea oil
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/808—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package for immersion in the liquid to release part or all of their contents, e.g. tea bags
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mechanical Engineering (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 항비만 녹차 및 그의 제조방법에 관한 것이다. 더욱 상세하게는 녹차와 비만억제작용이 있는 천연 한약재들을 적절히 배합하여, 이러한 녹차와 천연 한약재들로 구성된 감비차료방에 대한 항비만성의 효능에 대한 검증결과를 토대로 영양성과 기호성이 있는 분말상 또는 액상으로 제조하는 항비만 녹차 및 그의 제조방법에 관한 것이다.The present invention relates to anti-obesity green tea and a method of manufacturing the same. More specifically, by blending green tea and natural herbal medicines with an anti-obesity effect, based on the results of the verification of the anti-obesity effect on these green teas and the gambichachabang consisting of natural herbal medicines in the form of powder or liquid with nutrition and preference It relates to an anti-obesity green tea to be produced and a method for producing the same.
찻잎의 비만억제 효능은 옛부터 수없이 알려진 효능으로 「본초습유」에서는찻잎이 "사람의 기름기를 뺀다"고 했으며, 청나라 「본초비요(本草備要)」는 "기름진 음식물과 타고 지진 음식물의 독을 풀어버리고 대소변을 잘 나오게 하고 오래 마시면 기름기를 빼버린다"고 하여 인체에 불필요한 지방제거에 대한 효능을 말해주고 있다.The effect of tea leaves on obesity has been known for a long time. In "Herbal milk", tea leaves are said to "deplete human oil", and the Qing Dynasty "Bonchobiyo" is the poison of oily foods and earthquake foods. Loosen the stool to get out of the urine well and drink a long time to get rid of greasy, "says the effect on unnecessary fat removal to the human body.
인체의 효능과 관련이 있는 찻잎의 다양한 성분중 폴리페놀류인 카테친성분은 차잎중에 10∼18% 정도 함유되어 여러가지 작용을 하는데, 비만과 관련하여 체내중금속제거, 변비개선과 함께 강력한 항산화 물질로 작용하며 특히 녹차에는 다량 함유되어 있다.Among the various components of tea leaves, which are related to the efficacy of the human body, catechins, which are polyphenols, contain about 10-18% of tea leaves and perform various functions.In addition, they act as powerful antioxidants along with elimination of heavy metals and improving constipation. In particular, green tea contains a large amount.
차의 소식해주(消食解酒), 소지경신(消脂輕身), 이대소편(利大小便), 이습이수(利濕利水), 생진지갈(生津止渴), 청열해서(淸熱解暑) 등은 항비만성, 항산화성 및 생체조절성이 있는 폴리페놀성분인 카테친과 관련된 작용으로 차가 체내의 열이 올라 변비가 오는 것을 막고 지방이 가져다주는 불쾌감을 덜어주며 이뇨와 분변을 통한 체내 배설작용을 말한다.News of tea, Soji-shin, Idae-so, Isu-e-su, I-jinji-jigal, Clear water暑) is related to catechin, a polyphenolic component with anti-obesity, antioxidant, and bioregulatory effect, which prevents the car from heating up and prevents constipation, reduces discomfort caused by fat, and excretion through body diuresis and feces. Speak action.
혈관내벽에 쌓인 독성이 강한 산화된 저밀도 단백질(Oxid LDL)의 생성은 혈관내에 콜레스테롤 및 콜레스테릴 에스테르(cholesteryl ester)상태로 축적되어 발포 세포(foam cells)를 형성하여 동맥경화를 일으킨다. 차의 카테친 성분은 이러한 동맥경화의 원인이 되는 LDL의 산화에 대한 강력한 항산화 효과가 알려져 있다. 또한 혈장 및 간장의 콜레스테롤을 감소시키는 한편 콜레스테롤 재흡수 억제작용 등이 밝혀져 체내의 콜레스테롤 저하와 비만세포의 히스타민 유리억제 활성등으로 항비만 효과도 알려져 있다. 특히 체지방 증가억제에 대한 카테친 효과는 소장의 소화효소작용을 방해하여 과잉된 영양소의 흡수억제와 분변을 통한 배설작용을 도와 체지방의 축적을 억제시키는데, 이러한 작용은 카테친이 혈중 인슐린 농도를 저하시켜 혈액중의 혈당치를 낮아지게 하여 체지방을 억제시키는 것으로 알려져 있다.The production of highly toxic oxidized low density proteins (Oxid LDL) accumulated in the inner walls of blood vessels accumulate in the blood vessels as cholesterol and cholesteryl esters, forming foam cells, leading to atherosclerosis. The catechin component of tea is known to have a strong antioxidant effect on the oxidation of LDL, which causes this atherosclerosis. In addition, anti-obesity effects are known to reduce cholesterol and hepatic cholesterol while inhibiting cholesterol resorption, such as lowering cholesterol in the body and inhibiting histamine release of mast cells. In particular, the catechin effect on the inhibition of body fat increase interferes with the digestive enzyme function of the small intestine, thereby suppressing the absorption of excess nutrients and excretion through feces, which inhibits the accumulation of body fat. It is known that the blood sugar level in the body is lowered to suppress body fat.
카테친 성분의 또 다른 장점은 뛰어난 해독작용으로 체내에 축적된 약제과용과 독성에서 오는 해로움을 무력화 시키는 작용이 우수해 차처럼 오랜 음용시에도 부작용은 없는 것으로 알려져 있다. 이처럼 상기와 같은 약리작용을 하는 이유는 카테친이 화학 구조상 수산기(OH)가 많아 다른 물질과 쉽게 결합해 그 물질의 성질을 변화시키고 억제시키기 때문이다.Another advantage of catechin ingredient is that it has excellent detoxification effect, which is effective in neutralizing the harmful effects from overdose and toxicity accumulated in the body. The reason for the above pharmacological action is that catechins have a large number of hydroxyl groups (OH) due to their chemical structure, and easily combine with other substances to change and inhibit the properties of the substances.
차에 함유된 비타민과 메티오닌 등도 지방대사를 조절하는 기능을 가지는데, 이것은 메티오닌이 항지간성인자(抗脂肝性因子)로 간에 지방이 침투하는 것을 저해하여 간경화증을 유발하는 지방성 간을 억제시키는 것으로 알려져 있다.Vitamins and methionine in tea also have a function of regulating fat metabolism, which inhibits fatty liver infiltration of methionine into the liver and inhibits the fatty liver causing cirrhosis. It is known.
찻속의 알카로이드(alkaloid)성분으로 메틸크산틴(methylxanthin) 유도체들중 혈관확장제와 신경자극제로 작용하는 카페인의 활성작용은 카테친의 억제작용과 데아닌(Theanine)성분의 선택적 조절작용을 받아 중추신경계통이 확장되지만 뒤따라 억제작용이 나타나면서 속효성 생리작용(速效性 生理作用)을 일으킨다. 이와 같은 카페인의 특성은 흥분, 강심, 이뇨, 해열, 수렴 등의 다양한 약리학적 작용을 나타내는데, 특히 폴리페놀성분들과 협동작용하여 인체내에 콜레스테롤 함량이 많아지는 것을 방지하여 협심증(心絞痛), 심근경색을 치료하는 유익한 역할을 한다. 이때의 폴리페놀 성분은 혈관에서 피를 잘 통하게 하는 비타민 D역할과 비슷하다.Caffeine, which acts as an vasodilator and neurostimulant among methylxanthin derivatives as alkaloids in tea, is affected by catechins and selective regulation of theanine components. This is extended but followed by inhibitory action, causing fast-acting physiological action (速效性 生理 作用). Such caffeine has various pharmacological effects such as excitement, cardiac, diuresis, antipyretic and convergence. In particular, it works with polyphenols to prevent the increase of cholesterol content in the body, preventing angina and myocardial infarction. Plays a beneficial role in treating. At this time, the polyphenol component is similar to the role of vitamin D through blood vessels well.
상기에서 언급한 바와 같이 찻잎에 함유된 폴리페놀 성분인 카테친과 카페인, 비타민 등이 인체내에서 나타내는 다양한 약리작용은 혈중 콜레스테롤 저하, 고혈압과 동맥경화증 억제, 과산화지질 생성억제로 노화예방, 혈중지질농도 저하, 중성지질의 생성억제로 비만방지, 모세혈관 저항력 증진 등의 성인병을 억제하는 효능이 크므로 차는 성인병에 대한 아주 중요한 예방기능을 갖고 있다.As mentioned above, the various pharmacological effects of catechins, caffeine, and vitamins, which are contained in tea leaves, in the human body are shown to prevent aging by inhibiting blood cholesterol, suppressing hypertension and atherosclerosis, and inhibiting lipid peroxidation. Tea has a very important preventive function against adult diseases because it has a great effect of suppressing adult diseases such as obesity prevention and capillary resistance by inhibiting the production of hypolipidemia.
선진국일수록 비만과 함께 고지혈증, 고혈압, 동맥경화와 같은 체내 지질축적에서 오는 현대인의 성인병 문제는 심각하며, 비만은 주로 고지방, 고단백 식품을 과식해서 오는 경우가 많다. 이러한 식품의 과식은 지방신진대사의 기능이 문란해지고 지방과 단백질의 소화흡수에 영향을 주어 살이 너무 찌고 혈지가 높아진다. 이 경우, 적당한 약물치료와 건신운동(健身運動)을 통하여 살을 빼고 병을 치료하는 것을 감비라고 한다. 즉 감비는 비대한 사람이나 몸매를 늘씬하게 가꾸고 싶은 여성들의 미용을 위한 체중감량 또는 체중감량을 위한 식이요법이나 감식을 말한다. 비만환자에게는 두 가지 경우가 있는데, 하나는 단순성 비만으로 몸집이 방대하여 운동하기 힘들며 움직이면 숨이 가쁜 경우고, 다른 하나는 체질적인 비만으로 고혈압, 고혈지, 관상동맥경화증을 겸하고 있다.In advanced countries, obesity is a serious problem of adult diseases caused by the accumulation of lipids in the body such as hyperlipidemia, hypertension, and atherosclerosis, and obesity is often caused by overeating high-fat foods. Overeating these foods leads to disturbed fat metabolism and affects the digestion and absorption of fat and protein, resulting in too fat and high blood levels. In this case, it is called Gambi to treat the disease by losing weight through proper medication and healthy exercise (健身 運動). In other words, Gambi is the weight loss for beauty or the diet or diet for weight loss of bloated people or women who want to slim down. There are two cases of obese patients, one is simple obesity because of its large size, difficult to exercise and short of breath when moving, and the other constitution is obesity, hypertension, hypertension, coronary atherosclerosis.
오늘날의 비만환자의 대부분은 후자인 경우가 많다. 대부분의 감비법은 비만증 발생후 치료만을 위주로 하기 때문에 이미 고혈압이나 동맥경화와 같은 합병증을 유발한 경우가 많고 증세에 따른 치료효과도 남녀노소에 따라 차이가 있어 오늘날 현대인에게는 예방과 치료를 겸한 건신감비(健身減肥)한 감비제의 개발이 더욱 필요하다.Most obese people today are the latter. Since most sensitization methods mainly focus on treatment after the development of obesity, there are many cases of complications such as hypertension or arteriosclerosis, and the treatment effects according to the symptoms also vary between men and women. It is necessary to further develop a secretive agent.
한편, 상용차료방(常用茶療方)이란 차를 이용한 복방응용형으로 차 또는 찻잎을 주약 혹은 보조약으로 하여 다른 한약재와 함께 배합하여 복용하며, 제형은 현대에 맞게 티백용과 캔음료용으로 제조하여 일상의 차처럼 마시면서 병을 치료하거나 예방하는 것을 말한다. 현대 한약의 발전에서 가장 주목되는 점은 상용차료방이 약물의 독성과 부작용에 대한 염려에서 벗어난다는 것이며, 이러한 작용은 차의 폴리페놀인 카테친 성분에서 비롯된다고 하는 것이 이미 과학자들에 의해서 밝혀진 상태이다.On the other hand, commercial tea room (常用 이란 方) is a medicinal application using tea as tea or tea leaves as a main medicine or supplements, and combined with other herbal medicines, and the formulation is prepared for tea bags and canned drinks according to modern times. Drinking like everyday tea is to cure or prevent illness. Most notable in the development of modern Chinese medicine is that the commercial room is free from concerns about the toxicity and side effects of the drug, and it has already been shown by scientists that this action comes from the catechin component of tea.
그러나, 한약재를 이용하여 만든 기호성 식품은 강한 한약냄새가 사람의 기호에 따라 그 선호도가 달라지는 특징이 있다. 이러한 한약재를 이용한 차는 한약재의 냄새가 싫고 좋음이 분명하여 기호식품개발에 대한 어려움이 많아 녹차에 한약재를 이용한 제품은 한정되어 있고, 개발된 제품의 효능을 입증하기가 어려워 차로서 개발된 제품은 거의 없다.However, the palatability food made by using the herbal medicine has a characteristic that the strong smell of Chinese medicine varies depending on the preference of the person. Tea using herbal medicines obviously do not like the smell of herbal medicines because there is a lot of difficulties in the development of preference foods, there are limited products using herbal medicines for green tea, and it is difficult to prove the efficacy of the developed products. none.
이에 본 발명자들은 비만을 방지할 수 있도록 차를 다른 한약과 배합하여 차의 특색과 찻잎의 효능을 포괄하면서도 찻잎이 지니고 있지 않는 효능이 발휘되고, 약물의 치료효과를 발휘하는데 도움을 주며, 약물의 용해를 촉진시키고, 향기를 증가시켜 약맛을 조절할 수 있는 세련되고 음용이 편리한 차료방을 연구하게 되었다.Therefore, the present inventors combine tea with other herbal medicines to prevent obesity, while exhibiting the features of tea and the efficacy of tea leaves, and exhibiting the efficacy of tea leaves, helping to exert the therapeutic effect of drugs, and Sophisticated and easy-to-use tearooms that promote dissolution and increase scent to control the taste are studied.
상기와 같은 효능을 바탕으로 개발된 감비차료방은 현대인에게 맞게 비만환자의 병리특징과 상용약재의 약리특성에 대한 인식을 응용하였기 때문에 현대의 성인병인 비만치료 특성에 잘 적용된다. 그리고 비만억제에 대한 효능을 입증하기 위해 동물실험을 수행한 결과 비만억제효과가 뛰어난 것으로 확인되어 이러한 결과를토대로 기능성과 기호성이 우수한 차가 제조됨을 확인하여 본 발명을 완성하기에 이르렀다.The gambichabang room developed on the basis of the above-mentioned efficacy is well applied to the characteristics of obesity treatment of modern adult diseases because the application of the pathological characteristics of the obese patients and the pharmacological characteristics of the commercial medicine to the modern people. And the results of animal experiments to prove the effect on the inhibition of obesity was confirmed to be excellent in the anti-obesity effect, based on these results confirmed that the excellent functional and palatability tea was made to complete the present invention.
따라서, 본 발명의 목적은 녹차와 비만억제용 한약재를 적절히 배합하고, 여기에 기호성 향상을 위해 현미 분말을 배합하여 현대인의 기호성, 대중성, 경제성 및 상품성 등을 고려한 이상적인 건신익수(健身益壽)한 항비만 녹차를 제공하는 것이다.Accordingly, an object of the present invention is to mix the green tea and anti-obesity medicinal herb appropriately, and to mix the brown rice powder to improve the palatability, which is an ideal dry picking in consideration of the palatability, popularity, economy and commerciality of modern people. It is to provide anti-obesity green tea.
또한, 본 발명의 목적은 한약 특유의 강한 향과 맛의 개선을 통한 기호성 증가와 제품의 저장안정성 및 감지감비(消脂減肥)효능을 높인 고기능성 차를 언제, 어디서나 음용이 편리한 티백용 분말차와 캔음료용 액상차로 제조하는 방법을 제공하는데 있다.In addition, an object of the present invention is a tea bag powder tea convenient to drink anytime, anywhere high functional tea with increased palatability and improved storage stability and sensitivity of the product by improving the strong aroma and taste unique to Chinese medicine And to provide a method for producing a liquid tea for canned beverages.
다른 한편으로는 본 발명의 목적이 부작용과 독성이 없는 점을 착안하여 일상 상용차로서 평상시 계속적인 음용을 통해 비만증 치료와 예방을 겸한 기능성 식품으로 국민보건에 이바지하는 것이다. 따라서 고지혈 억제와 지방분해성을 가지는 기능성차의 제조 공정을 위해 초제용 녹차와 비만억제용 한약재의 조성 및 혼합비율과 그 제조공정, 녹차와 비만억제용 한약재의 혼합처리에 의한 감비차료방의 제조공정, 감비차료방을 첨가한 식이군의 제조 및 동물실험을 통한 비만억제 효능에 대한 검증 결과를 제공하는 것이다.On the other hand, the object of the present invention is to contribute to the public health as a functional food that combines treatment and prevention of obesity through continuous drinking as usual commercial vehicles, taking into consideration that there are no side effects and toxicity. Therefore, the manufacturing and mixing ratio of herb tea and anti-obesity medicinal herb for the manufacturing process of functional tea having high cholesterol and fat degradability, and its manufacturing process, manufacturing process of fertilized tea room by mixing treatment of green tea and anti-obesity herbal medicine, It is to provide a verification result of the anti-obesity effect through the preparation of the diet group added with the gambichabangbang and animal experiment.
도 1은 본 발명에 따라 감비차료방(減肥茶療方)을 제조하는 과정을 나타낸 공정도이다.1 is a process chart showing a process for manufacturing a gambichabangbang (減肥 茶 療 方) according to the present invention.
도 2는 본 발명에 따라 분말성 현미와 감비차료방을 이용하여 티백용 항비만 녹차를 제조하는 과정을 나타낸 공정도이다.Figure 2 is a process chart showing a process for producing an anti-obesity green tea for tea bags using powdered brown rice and gambichabang according to the present invention.
도 3은 본 발명에 따라 액상의 캔음료용 항비만 녹차를 제조하는 과정을 나타낸 공정도이다.Figure 3 is a process chart showing a process for manufacturing a liquid canned anti-obesity green tea according to the present invention.
본 발명은 연자육 8 내지 20중량부, 동규자 8 내지 20중량부, 괴각 8 내지 20중량부, 적하수오 8 내지 20중량부, 진호로 8 내지 20중량부, 초결명 8 내지 20중량부, 택사 8 내지 20중량부, 대황 8 내지 20중량부, 옥수수수염 8 내지 20중량부, 산사육 8 내지 20중량부, 소태나무 4 내지 10중량부 및 상엽 4 내지 10중량부가 배합된 비만억제성 한약재 60 내지 80중량%와 녹차 20 내지 40중량%로 이루어진 감비차료방을 현미와 건조중량비 2:1 내지 4:1로 배합한 항비만 녹차이다.The present invention is 8 to 20 parts by weight, 8 to 20 parts by weight, gyuja 8 to 20 parts by weight, 8 to 20 parts by weight, 8 to 20 parts by weight dropping, 8 to 20 parts by weight, 8-8 parts by weight ultra-trick, taxi 8 To 20 parts by weight, rhubarb 8 to 20 parts by weight, corn mustache 8 to 20 parts by weight, mountain breeding 8 to 20 parts by weight, 4 to 10 parts by weight of bovine wood and 4 to 10 parts by weight of the anti-obesity herbal medicines 60 to 80 blended It is an anti-obesity green tea blended with a brown rice and a dry weight ratio of 2: 1 to 4: 1, consisting of 20% by weight and 20-40% by weight of green tea.
본 발명은 연자육, 동규자, 괴각, 적하수오, 진호로, 초결명, 택사, 대황, 옥수수수염 및 산사육을 각각 8 내지 20중량부로, 소태나무 및 상엽을 각각 4 내지 10중량부로 배합, 증숙, 볶음, 건조 및 분쇄하여 비만억제성 한약재 분말을 얻는 제 1 공정, 상기 비만억제성 한약재 분말을 녹차 분말과 건조중량비 6:4 내지 8:2로 정량, 배합하여 감비차료방을 얻는 제 2공정, 및 상기 감비차료방에 증숙시킨 후 100 내지 180℃에서 볶은 현미 분말을 건조중량비 2:1 내지 4:1로 혼합하고, 분말성 향료 0.02 내지 0.06%(w/w %)을 첨가하여 혼합하는 제 3공정으로 이루어진 분말성 티백용 항비만 녹차의 제조방법이다.In the present invention, 8 to 20 parts by weight of lotus root, Donggyuja, crust, drooping water, Jinhoro, super-determination, talc, rhubarb, corn beard and hawthorn, respectively, 4 to 10 parts by weight of bovine wood and upper leaf, respectively, steaming, roasting , A first step of drying and pulverizing to obtain an obesity inhibitory medicinal herb powder, a second step of quantifying and blending the obesity inhibitory medicinal herb powder with green tea powder in a dry weight ratio of 6: 4 to 8: 2, and obtaining a nutrient-free tea room, and A third step of mixing the brown rice powder roasted at 100 to 180 ° C. after steaming in the fermented tea room mixture at a dry weight ratio of 2: 1 to 4: 1, and adding and mixing powdered flavoring 0.02 to 0.06% (w / w%). It is a manufacturing method of the anti-obesity green tea for powdered tea bags.
또한, 본 발명은 연자육, 동규자, 괴각, 적하수오, 진호로, 초결명, 택사, 대황, 옥수수수염 및 산사육을 각각 8 내지 20중량부로, 소태나무 및 상엽을 각각 4 내지 10중량부로 배합, 증숙, 볶음, 건조 및 분쇄하여 비만억제성 한약재 분말을 얻는 제 1공정, 상기 비만억제성 한약재 분말을 녹차 분말과 건조중량비 6:4 내지 8:2로 정량하여 혼합되지 않은 감비차료방을 얻고, 증숙시킨 후 100 내지 180℃에서 볶은 현미 분말을 상기 감비차료방에 대해 건조중량비 2:1 내지 4:1로 정량하는 제 2공정, 제 2공정에서 감비차료방중 비만억제성 한약재와 현미를 혼합하여 1차 추출여과하고, 녹차는 2차 추출여과하는 제 3공정, 및 제 3공정에서 얻은 1차 추출물과 2차 추출물을 감압여과한 후 혼합하고, 여기에 비타민C0.02 내지 0.04%(w/v%)와 액상 항료 0.02 내지 0.08%(v/v %)을 첨가하는 제 4공정으로 이루어진 캔음료용 액상 항비만 녹차의 제조방법이다.In addition, the present invention is 8 to 20 parts by weight of lotus roots, Donggyuja, crust, red sewage, Jinhoro, super-determination, taeksa, rhubarb, corn beard and mountain breeze, respectively, 4 to 10 parts by weight of bovine and upper leaves, respectively, steaming In the first step to obtain the anti-obesity herb powder by stirring, drying and pulverizing, the obesity-inhibiting herb powder is quantified in green tea powder and dry weight ratio 6: 4 to 8: 2 to obtain unmixed gambichabangbang, steaming After mixing the brown rice powder roasted at 100 to 180 ℃ to the dry weight ratio 2: 1 to 4: 1 with respect to the non-fermented tea room by mixing the obesity-inhibitory herbal medicine and brown rice in the fertilizer tea room in the second process 1 Tea extraction and filtration, green tea is the second extraction filtration of the third step, and the primary extract and secondary extract obtained in the third step and filtered under reduced pressure, and then mixed with vitamin C 0.02 to 0.04% (w / v% ) And 0.02 to 0.08% (v / v%) liquid liquid It is a method of producing a liquid anti-obesity green tea for canned drinks made in a fourth step.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명인 항비만 녹차에 사용된 주요 재료는 녹차에 비만억제에 효능이 있는 천연한약재를 배방하여 제조한 우수한 감비차료방이다. 본 감비차료방의 특징은 전통적 인식을 토대로 현대적 연구결과를 결합시켜 만든 감비차료방이며, 다른 한편으로는 전통과 현대적인 방법을 고려하여 제조한 감비차료방(減肥茶療方)이기 때문에 구성이 합리적이고 동물실험결과 감비효력이 좋아서 비만환자들에 대한 치료는 몰론 남녀노소 누구나 평상시 음용으로 비만을 예방하거나 치료할 수 있는 기능성과 기호성을 겸한 우수한 감비차료방이다.The main material used in the anti-obesity green tea of the present invention is an excellent gambichabangbang produced by distributing natural herbal medicine that is effective in inhibiting obesity in green tea. The feature of the Gambia Tea Room is Gambia Tea Room, which is a combination of modern research results based on traditional perception. On the other hand, the Gambia Tea Room is manufactured in consideration of tradition and modern methods. As a result of animal experiments, the sensitizing effect is good, so the treatment of obese patients is an excellent ambience-charging room that combines functionality and palatability that prevents or treats obesity by drinking for everyone.
본 발명의 항비만 녹차에 사용된 한약재는 특히 현대인의 성인병 원인이 되고 비만증 환자 대부분이 고혈지, 고혈압을 겸하고 있으므로 고지혈증 억제와 지방분해에 효능이 있는 약재들로 구성하였다. 구체적으로, 연자육, 동규자, 괴각, 적하수오, 진호로, 초결명, 택사, 대황, 옥수수수염, 산사육, 소태나무 및 상엽을 배합하였다.The herbal medicine used in the anti-obesity green tea of the present invention is a cause of adult disease in modern people, and most obesity patients are combined with high blood pressure and hypertension, so it is composed of drugs that are effective in suppressing hyperlipidemia and lipolysis. Specifically, lotus root, Donggyuja, crustacean, drip Sewao, Jinhoro, super-determined, Taeksa, rhubarb, corn mustache, hawthorn, pine needles and upper leaves were combined.
상기 한약재들의 각각을 약리적 효능면에서 살펴보면 다음과 같다(약품식물학 가론, 본초학, 약초의 성분과 이용, 한국의 보약, 동의보감).Looking at each of the medicinal herbs in terms of pharmacological efficacy is as follows (pharmaceutical botanical theory, herbal medicine, ingredients and use of herbs, Korea's remedy, consent bogam).
괴각, 적하수오, 산사육은 혈중지질을 제거하고 체중을 감소시켜 건신익수 (健身益壽)하는 약재들로 비대증과 고지혈증에 적용되는 약재들이다. 이들중 산사육은 전통적으로 비장을 강하게 하여 소화를 시키는 효능이 있어 특히 지방살이 축적된 고기, 기름기와 육체(肉滯)를 잘 소화시킬 뿐만아니라 혈분으로 들어가 활혈화어(活血化瘀)하여 부기를 빼는 효능을 갖고 있다. 적하수오는 중추신경계통에 대한 흥분작용과 장연동운동을 강화시켜 약한 설사작용을 하며, 흰쥐의 동물실험에서 물추출액은 간글리코겐량을 6배로 높였으며, 달임약은 흰쥐의 혈청콜레스테롤과 혈당값을 낮추는 작용이 있다. 따라서 산사육과 괴각, 적하수오를 배방한 차는 살찐 사람과 혈중지질이 높으면서 비대증인 환자들이 이 차를 마시면 좋은 효과를 볼 수 있다.Nucleus, drooping and mountain breeding are medicines that are applied to hypertrophy and hyperlipidemia by eliminating blood lipids and losing weight. Among them, mountain cultivation is traditionally effective in strengthening the spleen and digesting it, and in particular, digests meat, oil, and flesh, which have accumulated fat, as well as enters the blood powder to remove swelling by activating blood. It has efficacy. Drainage has weak diarrhea by strengthening the excitatory and intestinal synergistic movements of the central nervous system.In animal experiments of rats, water extract increased liver glycogen levels 6-fold, and decoction of serum cholesterol and blood glucose levels in rats. There is a function to lower. Therefore, cultivation, eccentricity, and drainage of tea are fat people and people with high blood lipids and hypertrophy can drink this tea to have a good effect.
동규자씨에는 단백질과 15∼30%의 지방유 등이 풍부하여 이뇨작용, 수종, 윤장통변(潤腸通便)효과에 의한 대변조결(大便燥結)치료, 유방팽창치료 등에 쓰인다.Dong Kyu Ja is rich in protein and 15-30% fatty oil, and it is used for diuretic effect, edema, stool constipation treatment, and breast expansion treatment.
초결명은 혈압을 낮추며 대장을 자극하여 통변에 이롭고 완화, 이뇨작용이 있어 대변이 굳고 혀가 건조할 때 좋다.It is good for lowering blood pressure and stimulating the large intestine, which is beneficial for pain, and it has relief and diuretic effect.
연자육은 비타민 B1결핍증과 만성장염치료, 건위, 강장제로 스테미너를 길러주면서 살을 빼준다.Yeonjagi loses weight by growing stamina with vitamin B 1 deficiency, chronic enteritis treatment, health and tonic.
진호로는 냉기를 제거하는 습성이 강해 한비, 습비, 각기로 인한 냉병, 복통, 위경련, 콩팥결석, 방광마비, 오줌소태 , 신경쇠약 등에 사용한다.Jinhoro has a strong habit of removing cold air, so it is used for cold rain, wet rain, cold diseases caused by various diseases, abdominal pain, stomach cramps, kidney stones, bladder palsy, urinary tract, and nervous breakdown.
택사는 이뇨와 신염에 좋고 동물실험에서 간장의 콜레스테롤량을 현저히 저하시켜 간지방 축적이 억제된 것으로 보고 되어 고지혈증에 효능이 좋은 것으로 알려져 있다.Taxa is known to be good for diuresis and nephritis and has been reported to inhibit liver fat accumulation by significantly lowering the amount of cholesterol in the liver in animal experiments.
대황(大黃)은 만성변비, 황달, 소변이상, 사하약(瀉下藥), 고혈압용 약으로 쓰이는데 센노사이드(sennoside)는 대장 내의 세균에 의해 레인 안트론(rhein anthron)을 생성하고 이것은 장연동 운동의 촉진, 수분 및 Na 흡수저해, 점액분비에 의한 사하작용(瀉下作用)이 알려져 있다.Rhubarb is used for chronic constipation, jaundice, urine dysfunction, Sakha medicine, and high blood pressure medicine. Sennoside produces rhine anthron by bacteria in the large intestine. It is known to lower the action by promoting exercise, inhibiting water and Na absorption, secretion of mucus.
옥수수수염은 많은 양의 KNO3를 함유하며 이뇨제, 이담작용(利痰作用) 등이 있어서 당뇨병, 고혈압, 방광염, 콩팥염 등에 사용한다.Corn beard contains a large amount of KNO 3 and is used for diabetes, hypertension, cystitis and kidney disease due to diuretics and diarrhea.
소태나무는 고미건위약으로 항균작용과 위액분비를 돕기 때문에 소화불량, 위염, 식욕부진에 사용한다.Pinewood is a high-density placebo that helps with antibacterial activity and secretion of gastric juice, which is used for indigestion, gastritis and anorexia.
상엽은 비타민, 무기질, 단백질 등 영양소가 풍부하며, 혈압과 혈당을 내려주고 이뇨, 당뇨, 혈압하강 치료제로 쓰인다.The upper leaf is rich in nutrients such as vitamins, minerals, and proteins. It lowers blood pressure and blood sugar, and is used to treat diuresis, diabetes, and lowering blood pressure.
이들 중 연자육, 동규자, 괴각, 적하수오, 진호로, 초결명, 택사, 대황, 옥수수수염 및 산사육은 각각 8 내지 20중량부로, 소태나무 및 상엽은 각각 4 내지 10중량부로 배합하는 것이 이들의 약리적 활성을 최대화할 수 있다. 바람직하기로는 연자육, 동규자, 괴각, 적하수오, 진호로, 초결명, 택사, 대황, 옥수수수염, 산사육, 소태나무 및 상엽이 건조중량비 1:1:1:1:1:1:1:1:1:1:0.5:0.5로 배합되는 것이다.Among them, it is pharmacologically formulated with 8 to 20 parts by weight of lotus roots, Donggyuja, crustacean, drip Shou, Jinhoro, super-determinate, taeksa, rhubarb, corn beard and mountain breeze, and 4 to 10 parts by weight of bovine wood and upper leaves, respectively. The activity can be maximized. Preferably, lotus root, Donggyuja, crust, droopy, Jinhoro, super-determined, talc, rhubarb, corn beard, hawthorn, pine and upper leaf dry weight ratio 1: 1: 1: 1: 1: 1: 1: 1: 1: 1: 0.5: 0.5.
본 발명의 항비만 녹차의 주성분인 녹차로는 일반적인 녹차를 분말화하여 사용할 수 있고, 바람직하게는 5월에 채취한 찻잎을 이용하는 것이 녹차 고유의 성분과 신선한 맛을 유지하는데 적합하다.As the green tea which is the main ingredient of the anti-obesity green tea of the present invention, it is possible to use general green tea powder, and preferably, the tea leaves collected in May are suitable for maintaining the unique ingredients and fresh taste of green tea.
따라서, 본 발명의 감비차료방은 녹차가 전체 20 내지 40중량%를 차지하고, 한약제인 연자육, 동규자, 괴각, 적하수오, 진호로, 초결명, 택사, 대황, 옥수수수염, 산사육, 소태나무 및 상엽 등으로 구성된 복합한약재가 60 내지 80중량%로 배합된다. 이와 같은 배합비율은 녹차와 천연한방재의 우수한 약리성분들의 상호작용으로 고지혈(高脂血) 억제와 지방제거작용을 효과적으로 한다.Therefore, the gambichabang of the present invention green tea occupies a total of 20 to 40% by weight, the Chinese herbal medicine yeonjak, Donggyuja, crust, red sesame, Jinhoro, ultra-determinate, taeksa, rhubarb, corn beard, mountain cultivation, saponica and upper leaves The compound herbal medicine consisting of 60 to 80% by weight is blended. This blending ratio is effective in inhibiting hyperlipidemia (高脂 血) and fat removal by the interaction of the excellent pharmacological components of green tea and natural herbal medicine.
또한, 본 발명의 항비만 녹차는 감비차료방에 그의 약리성을 유지하면서 기호성을 향상시키기 위해 현미분말을 2:1 내지 4:1의 건조중량비로 배합한다.In addition, the anti-obesity green tea of the present invention is blended with brown rice powder in a dry weight ratio of 2: 1 to 4: 1 in order to improve palatability while maintaining its pharmacological properties in the fermented tea room.
결국 본 발명의 항비만 녹차는 변비해소 및 배설작용이 뛰어나며, 위장과 장을 강하게 하여 건강하고 균형 있는 신체로 가꾸어 주도록 양생보건하는 우수한 비만억제차이다.Eventually, the anti-obesity green tea of the present invention is excellent in relieving constipation and excretion, it is an excellent obesity suppression car to cure health to strengthen the stomach and intestines to a healthy and balanced body.
또한 강제적 하리제를 사용하여 인위적인 하리를 유도한 기존의 감비제와는 달리 위와 장을 튼튼하게 하고 균형적인 건강을 유지하도록 건신익미(健身益美), 감비양생(減肥養生)에 중점을 두어 제조한 점이 본 발명의 큰 장점이다.Unlike conventional sweeteners that use artificial laxatives to induce artificial hari, it is manufactured with a focus on health benefits and health care to strengthen the stomach and intestines and maintain balanced health. This is a great advantage of the present invention.
이하, 티백용과 캔음료용 항비만 녹차의 제조방법과 비만억제 효능에 대한 기능성 검증을 위한 동물실험에 대하여 상세히 설명한다.Hereinafter, a method of preparing anti-obesed green tea for tea bags and canned beverages, and an animal experiment for verifying the functionality of the anti-obesity effect will be described in detail.
제 1공정 : 비만억제성 한약재 제조Step 1: manufacture obesity-inhibitory herbs
비만억제성 한약재는 먼저 상엽의 부드러운 순을 채엽하여 증열시간 45초로 맞춘 찐차용 증열기로 쪄서 80℃의 차건조기에 넣어 함수량 5% 정도로 건조시킨 후 무게비율로 정량한다. 상엽을 제외한 나머지 비만억제용 한약재의 각 약재들은 건조중량별로 정량한 후 정선하여 가볍게 세척한다. 세척후 동규자, 옥수수수염을 제외한 증숙할 약재들은 압력 찜통에서 증기가 나올때까지 쪄 놓으며, 물기를 뺀 동규자는 80℃에서 건조하여 불기가 약한 덖음솥(가마솥 내부온도 약 80∼100℃)에서 약간 구수한 냄새가 날 때까지 덖어 준다. 세척된 옥수수수염, 증숙된 약재들은 차건조기에 각각 따로 넣어 80℃의 온도로 함수량 5%이하가 되게 건조시킨다. 건조된 각 약재들과 상엽, 볶은 동규자 등을 혼합하여 비만억제용 한약재를 얻는다.Obesity inhibitory Chinese herbal medicine is first steamed by steaming steamed steamer with 45 seconds of steaming time after harvesting the tender leaves of the upper leaves, and put into a tea dryer at 80 ℃ and dried at a water content of about 5%. Except for the upper lobe, each of the herbs for restraint obesity is quantified by dry weight, and then selected and washed lightly. After washing, steaming herbs, except for copper and cornbeard, are steamed until steam comes out from the pressure steamer, and the dried copper is dried at 80 ℃ and slightly dried in a weakly steamed pot (about 80-100 ℃ inside the cauldron). Steam it until it smells. Washed corn beard and steamed herbs are put separately in the tea dryer and dried to a water content of 5% or less at a temperature of 80 ℃. Each dried herbs, lettuce, roasted Donggyuja, etc. are mixed to obtain an herbal medicine for obesity.
상기 비만억제용 한약재를 분쇄기에서 메쉬 크기가 4.0∼2.0㎜(캔추출용) →2.0∼1.0㎜(티백용)순으로 각각 분쇄하여 비만억제용 한약재 분말을 얻는다.The obesity inhibiting herbal medicines are pulverized in the order of 4.0-2.0 mm (for can extraction) → 2.0-1.0 mm (for tea bags), respectively, in a grinder to obtain an obesity-inhibiting herbal medicine powder.
제 2공정 : 감비차료방의 제조Second Process: Manufacturing of Fertilized Tea Room
가. 녹차의 제조end. Manufacture of Green Tea
재배종 찻잎을 채취하여 찐차용 첫물차 표준공정에 따라 제다한 초제차인 녹차를 주원료로 한다. 상기 녹차를 분쇄기에서 메쉬 크기가 4.0∼2.0㎜(캔추출용) →2.0∼1.0㎜(티백용)순으로 각각 분쇄하여 녹차 분말을 얻는다.Cultivated tea leaves are collected, and green tea, which is a variety of herb teas, is prepared according to the standard process of the first tea for steamed tea. The green tea is pulverized in the order of 4.0-2.0 mm (for can extraction) → 2.0-1.0 mm (for tea bag) in a grinder to obtain green tea powder.
나. 녹차와 비만억제용 한약재의 혼합I. Mixing Green Tea with Herbs
제 1공정에서 얻은 비만억제용 한약재와 상기 녹차분말을 건조중량비율(w/w %) 6:4 내지 8:2로 각각 정량하여 캔음료용 감비차료방으로 사용하며, 또 정량된 녹차와 비만억제용 한약재 분말을 혼합기에 넣어 잘 혼합하면 티백용 감비차료방이 얻어진다.Obesity-suppressing herbal medicines obtained in the first step and the green tea powder were quantified in dry weight ratio (w / w%) 6: 4 to 8: 2, respectively, and used as canned sweetened tea room. Put the inhibitory herbal powder in a mixer and mix well to obtain a tea bag gambangchabang.
제 3공정 : 제품화 공정3rd step: commercialization process
가. 현미의 전처리 및 분말 제조end. Brown Rice Pretreatment and Powder Preparation
본 발명에서는 제 2공정에서 얻어진 감비차료방이 액상 캔음료나 분말성 티백제품으로 사용할 경우 열수추출이나 침출시 강한 한약냄새와 쓴맛, 떫은 맛 등이 강해지는 경향이 있으므로 이들을 순화하고 전체적인 향미가 조화되도록 하기 위한 기호성 향상이 중요한 문제가 된다. 따라서 음용시 거부감이 없고 누구나 즐겨 마실 수 있도록 향미를 개선시키기 위해 상기 항비만 녹차에 볶은 현미를 첨가하기 위한 다음 공정을 실시하여 기호성을 향상시켰다.In the present invention, when the fermented tea room obtained in the second step is used as a liquid canned drink or powdered tea bag product, there is a tendency for strong herbal smell, bitter taste, and astringent taste to be strong during hot water extraction or leaching, so that the overall flavor is balanced. Enhancement of palatability is an important problem. Therefore, in order to improve the flavor so that anyone can enjoy drinking without the refusal to drink the following process for adding roasted brown rice to the anti-obesity green tea to improve the palatability.
현미를 정선·수세한 다음 바로 100℃온도에서 30분∼1시간동안 증숙시켜 꼬드밥을 만든 후 건조기용 발에 펴서 건조온도 80℃에서 3∼4시간 정도로 건조시킨 것을 현미의 전처리 과정으로 하였다.Immediately after picking and washing brown rice, steamed steamed at 100 ° C. for 30 minutes to 1 hour to make kodap, which was spread on a dryer foot and dried at 80 ° C. for 3 to 4 hours as a pretreatment process of brown rice.
차덖음용 가마솥 온도를 100∼180℃로 하여 전처리된 현미를 타지 않도록 미황색에 도달할 때까지 볶는다. 볶은 현미는 분쇄기에서 4.0∼2.0㎜(캔음료용), 2.0∼1.0㎜(티백용)의 메쉬크기로 분쇄하여 현미 분말을 얻는다.Set the temperature of the cauldron for simmering to 100-180 ° C. and fry until it reaches slightly yellow color so as not to burn the pretreated brown rice. Roasted brown rice is pulverized with a mesh size of 4.0-2.0 mm (for canned beverages) and 2.0-1.0 mm (for tea bags) in a grinder to obtain brown rice powder.
녹차에 섞는 현미의 종전의 가공방식은 현미를 정선, 수세한 후 바로 볶거나 수세후 건조하여 볶아서 사용하는 예가 많아 볶을 때 까맣게 잘 타고 분쇄시 쌀알 자체로 분쇄되는 예가 많았다. 이러한 방식은 현미·녹차를 가공할 경우 녹차보다 현미의 외관밀도가 커 가공중에 현미와 녹차를 섞을 경우 현미만 한쪽으로 몰리는 경향이 있어 잘 혼합되지 않는다. 또한 이러한 방식으로 제조된 현미·녹차를 열수에 침출할 경우 전분의 호화성이 적어 풀림성과 침출성이 떨어져 구수한 향미의 저하가 큰 것도 단점이었다.In the conventional processing method of brown rice mixed with green tea, there are many examples of using brown rice immediately after washing and washing with brown rice, or drying and washing it after washing with water. In this method, the appearance density of brown rice is higher than that of green tea when processing brown rice and green tea, and when brown rice and green tea are mixed during processing, only brown rice tends to be driven to one side, so it is not mixed well. In addition, when leached brown rice and green tea prepared in this manner in hot water, starch was less gelatinizable, so that the loosening and leaching was poor, and the deterioration of the flavor was greatly reduced.
그러나 본 발명에서 사용된 현미의 가공방식은 시루에 찐 후 건조하여 볶기때문에 전분 호화성이 증가되고 볶음중에 현미 밥알이 조금 부풀면서 표면색이 미황색으로 되는 동안 누릉지와 같은 구수한 맛이 강해지는 장점이 있다. 또한 전분의 호화성 증가는 외관밀도를 작게하여 분쇄후 다른 분말성 혼합물과도 잘 섞이는 장점이 있으며 열수에 대한 풀림성과 침출성이 좋고 침출시 구수한 향미가 강한 것이 큰 특징이다. 따라서 이와 같이 제조된 현미분말은 향미 증진제인 부원료로 바람직하게 사용된다.However, the processing method of brown rice used in the present invention has the advantage that the starch gelatinization is increased because the steamed rice is steamed and then roasted, and the brown rice grain is slightly swollen during roasting, while the surface color becomes pale yellow. . In addition, the increase in gelatinization of starch has the advantage of being well mixed with other powdery mixtures after grinding by reducing the appearance density, and is characterized by high loosening and leaching properties of hot water and strong flavor when leaching. Therefore, the brown rice powder thus prepared is preferably used as an auxiliary ingredient which is a flavor enhancer.
나. 분말성 티백용 항비만 녹차의 제조I. Preparation of Anti-Obesity Green Tea for Powdered Tea Bags
제 2공정에서 얻어진 감비차료방 분말과 상기 현미 분말을 2 : 1 내지 4 : 1의 건조중량비로 혼합한 후 분말성 향료 0.02∼0.06%(w/w %)를 첨가하여 혼합기에 넣어 30∼50분간 잘 혼합함으로써 요구하는 분말성 티백용 항비만녹차가 얻어진다.After mixing the persimmon tea room powder obtained in the second step and the brown rice powder in a dry weight ratio of 2: 1 to 4: 1, add 0.02 to 0.06% (w / w%) of powdered flavor and add to the mixer 30 to 50 By mixing well for a minute, an anti-obesity green tea for powdery tea bags is obtained.
이와 같은 방법을 실시함으로써 얻어진 감비차료방, 분말 현미 등의 제조공정 및 전처리 등의 일련의 제조과정을 거치면서 제조된 분말성의 티백용 항비만 녹차는 열수에 침출이 잘되고 볶은 현미의 구수한 맛과 식용향료의 첨가로 한약의 강한 냄새가 완화되면서 부드럽고 구수한 향미가 증가되어 기호성이 향상된 차를 얻을 수 있다.The anti-obesity green tea for powdered tea bags prepared through a series of manufacturing processes such as gambichabangbang, powdered brown rice, etc. obtained by performing such a method, and pretreatment is well leached in hot water and consumed with the delicious taste and edible taste of roasted brown rice. With the addition of fragrance, the strong odor of Chinese medicine is alleviated, and the soft and delicious flavor is increased to obtain tea with improved palatability.
다. 액상의 캔음료용 항비만 녹차의 제조All. Preparation of Liquid Canned Anti-obesity Green Tea
제 2공정에서 배합 비율별로 계량된 혼합 직전의 감비차료방과 상기 현미분말을 2 : 1 내지 4 : 1로 준비한다. 캔음료를 추출하기 전 각 분말의 조성비(w/w %) 합계를 200g으로 할 때 추출할 열수의 양은 17∼22ℓ를 기준으로 한다.In the second step, the milled tea powder and the brown rice powder immediately before the mixing measured for each blending ratio are prepared from 2: 1 to 4: 1. When the total composition ratio (w / w%) of each powder is 200 g before canned beverage extraction, the amount of hot water to be extracted is based on 17 to 22 liters.
1차 추출방법으로 분말상태의 감비차료방중 먼저 비만억제용 한약재와 현미를 추출기에 혼합하여 넣고 이온교환수지된 열수 12∼15ℓ를 가하여 100℃에서 30분∼1시간(추출양에 따라 조정) 교반 추출하여 통상의 방법으로 원심분리한 후 여과한다. 녹차도 1차 추출과 동일한 방법으로 열수온도가 75 내지 85℃가 되면 5∼7ℓ를 가하여 20∼30분간(추출양에 따라 조정) 교반 추출후 원심분리하여 여과한다. 1차 추출액과 2차 추출액을 축냉제를 이용하여 20℃정도로 냉각시켜 감압여과 장치로 여과한 후 혼합한다. 혼합된 추출액에 비타민 C 0.02∼0.04%(w/v %), 액상향료 0.02∼0.08%(v/v %) 등을 조합하여 첨가시키고 평면식 열교환기에서 90±5℃로 가열시킨 후 캔에 뜨거울 때 충전시킨다. 혼합 추출액을 충전 시킨 후 캔음료의 헤드 스페이스부분에 질소가스를 주입시켜 제품의 용존산소량을 감소시킨 후 캔뚜껑으로 밀봉한다. 밀봉된 캔 제품은 살균, 냉각시켜 제품화한다.In the primary extraction method, firstly mix the herbal medicine for suppressing obesity and brown rice into the extractor in powder form and add 12-15 liters of hot water of ion-exchange resin and stir at 100 ℃ for 30 minutes to 1 hour (adjusted according to the extraction amount). Extraction and centrifugation in a conventional manner, followed by filtration. When the hot water temperature is 75-85 ° C., 5-7 L of green tea is added and stirred for 20-30 minutes (adjusted according to the extraction amount), followed by centrifugation and filtration. The primary and secondary extracts are cooled to about 20 ° C. using a coolant, filtered through a vacuum filter, and mixed. Vitamin C 0.02 ~ 0.04% (w / v%) and liquid fragrance 0.02 ~ 0.08% (v / v%) are added to the mixed extract and heated to 90 ± 5 ℃ in a planar heat exchanger. Charge when hot. After filling the mixed extract, nitrogen gas is injected into the headspace of the canned beverage to reduce the dissolved oxygen of the product and then sealed with a can lid. Sealed can products are sterilized and cooled to be commercialized.
여기에서, 한약재와 분말을 1차 추출하고, 녹차를 2차로 추출하는 것은 1차 추출온도에서 녹차 특유의 향미소실 및 엽록소와 비타민이 파괴되기 때문이다.Here, the first extraction of the herbal medicine and powder, and the second extraction of green tea is because the flavor loss and chlorophyll and vitamins unique to green tea are destroyed at the first extraction temperature.
본 발명의 제 2공정에서 얻어진 감비차료방은 열수 침출이나 추출시 강한 한약냄새와 쓴맛, 떫은 맛 등이 강해지는 경향이기 때문에, 이를 순화하고 전체적인 향미가 조화되도록 하기 위해서 볶은 현미와 향료를 첨가하고 캔음료 제조중에 비타민 C의 손실을 보강하고 제품의 저장성과 기능성을 향상시키기 위해 비타민 C를 첨가하였다.The gambichabangbang obtained in the second step of the present invention tends to have a strong herbal smell, bitter taste, astringent taste, etc. during hot water leaching or extraction, so that roasted brown rice and spices are added to purify and harmonize the overall flavor. Vitamin C was added to reinforce the loss of vitamin C during canned beverage production and to improve shelf life and functionality of the product.
종전의 생약재를 이용한 한방차나 토종 전통차의 추출방법은 전처리 과정을 거치지 않고 생약재를 곧 바로 열수 추출하는 예가 많기 때문에 추출시간이 4∼5시간 정도로 오래 걸리고 추출이 잘 안되는 문제점이 있었다. 그러나 본 발명에 의한 추출법은 녹차와 생약재를 먼저 찐차 제조공정과 증숙, 건조가공을 한 후 분말화시키는 전처리 과정을 거쳤기 때문에 녹차의 영양분을 살리면서 음료용 추출시 곧 바로 추출과정으로 들어갈 수 있으며, 가공된 분말상태로 대량저장이 가능하고 추출시 추출이 잘되고 추출시간을 크게 단축시킨 것이 본 발명과정의 특징이다. 이와 같은 방법으로 실시함으로써 얻어진 캔 음료용 항비만성 녹차는 가공중에 열수침출이 잘되고 추출시간의 단축 등으로 영양성분과 약리성이 균일한 품질의 음료를 얻을 수 있었다.Extraction method of traditional herbal tea or traditional Korean tea using traditional herbal medicines has a problem that the extraction time takes about 4 to 5 hours and does not extract well because there are many examples of extracting hot water immediately without going through the pretreatment process. However, the extraction method according to the present invention went through the pre-processing process of the green tea and herbal medicines first steamed tea manufacturing process and steaming, dried processing and then powdered, so that you can enter into the extraction process immediately when extracting for drinking while nourishing the green tea. It is a feature of the process of the present invention that bulk storage is possible in a powdered state, extraction is well performed and extraction time is greatly reduced. The anti-obesity green tea for canned beverage obtained by carrying out in this manner was able to obtain a beverage with good nutritional properties and pharmacological properties due to hot water leaching during processing and shortening of extraction time.
상기에서 첨가되는 비타민 C는 상승효과와 항산화제로서 녹차에 함유된 폴리페놀 성분과결합하여 상승 및 강한 항산화작용을 하게 된다. 특히 차의 폴리페놀 성분이 생체내의 활성산소나 라디칼을 소거하는 계가 존재하여 지질의 과산화를 억제시키고 생체의 항산화성을 유지시켜 주는데, 비타민 C는 이러한 효과를 더욱 증가 유지시켜 이것은 결국 혈중 콜레스테롤 함량 저하와 혈관벽을 강하작용을 한다. 즉 녹차의 폴리페놀성분이 카페인, 비타민 C, 비타민 E 등과 같이 공존해 있을 때 항산화성과 생리활성촉진이 더욱 상승되기 때문이다. 또한 비만억제성을 가지는 한약재들중 녹차의 폴리페놀 성분과 카페인 성분에 의해 약리적 효과가 더욱 활성촉진을 받아 효능이 증가되기도 한다.Vitamin C added in the synergistic effect and as an antioxidant is combined with the polyphenol component contained in green tea has a synergistic and strong antioxidant action. In particular, there is a system in which the polyphenol component of tea eliminates free radicals and radicals in the body, which inhibits the peroxidation of lipids and maintains the antioxidant properties of the body. Vitamin C further increases this effect, which in turn lowers the blood cholesterol content. Lowers the vessel wall. That is, when the polyphenol component of green tea coexists with caffeine, vitamin C, and vitamin E, antioxidant activity and physiological activity promotion are further increased. In addition, the pharmacological effect is further enhanced by the polyphenol component and caffeine component of green tea among the Chinese herbal medicines that have anti-obesity.
본 발명에서는 음용시 거부감이 없고 누구나 즐겨 마실수 있도록 향미를 개선시키기 위해서 상기 감비차료방에 덖음 현미, 향료를 첨가하여 기호성을 향상시킨다. 캔음료 제조중에 상승제인 비타민 C(L-Ascorbic acid)를 보충강화하여 녹차와 비만억제성 한약재의 생리활성촉진과 항산화성을 증가시켜 강지감비작용(降脂減肥作用)을 강화시키고 제품의 저장안정성을 높였다.In the present invention, there is no objection when drinking, and the taste is improved by adding the brown rice and flavoring to the fermented tea room to improve the flavor so that anyone can enjoy drinking. Enhancement of vitamin C (L-Ascorbic acid), a synergist during canned beverages, enhances the physiological activity and antioxidant properties of green tea and obesity-inhibiting Chinese herbal medicines Raised.
이와 같이 본 발명에 따라 제조된 분말성 티백용과 액상의 캔 음료용 항비만 녹차는 기능성이 뛰어난 비만억제용 차를 제조할 수 있으며, 저장성, 기호성, 기능성, 간편성 등이 우수하여 현대인의 대중 기호식품 또는 기능성 건강차로써 매우 적합하다고 할 수 있다.As described above, the anti-obesity green tea for powdered tea bags and liquid canned beverages prepared according to the present invention can be manufactured with excellent anti-obesity tea, and has excellent shelf life, palatability, functionality, simplicity, etc. Or it can be said to be very suitable as a functional health tea.
감비차료방을 첨가한 고지방식이군의 제조 및 동물실험을 통한 비만억제 효과 검증Production of High Fat Diet Group with Gambi-chachacha and Verification of Anti-obesity Effect through Animal Experiment
가. 연구내용end. Research contents
어떤 물질이 비만억제 효과를 가지고 있는 지를 조사하려면 우선 실험동물에서 지방축적의 증가를 유도하여야 하다. 실험동물에서 지방축적을 증가시켜 비만을 유도하는 다양한 방법들중 인위적인 스트레스를 주지 않고 자연적으로 비만을 유도하는 방법이 식이조절법인데, 그 중에서도 고지방식이를 섭취시키는 방법이 가능한 것으로 제시되고 있으며, 본 발명에서 이 방법으로 지방축적의 증가를 유도하고자 한다. 그러므로 본 실험에서는 대략 총섭취 열량의 55% 정도를 지방으로부터 얻게 만든 30% 지방식이를 실험동물에 섭취시킨후 체지방 축적과 에너지 균형의 변화를 조사하여 비만억제 효과의 실험에서 이 방법의 사용에 따른 타당성을 조사하였다.To investigate which substances have an anti-obesity effect, one must first induce increased fat accumulation in experimental animals. Among the various methods of inducing obesity by increasing fat accumulation in experimental animals, the method of naturally inducing obesity without artificial stress is a diet control method, and among them, the method of ingesting high fat diet is suggested. The invention seeks to induce an increase in fat accumulation. Therefore, in this experiment, after ingesting 30% fat diet obtained from 55% of total calorie intake into fat, the body fat accumulation and energy balance were investigated. The validity was investigated.
나. 실험재료 및 방법I. Experimental Materials and Methods
(1) 실험동물 : Sprague-Dawley male rat(1) Experimental animal: Sprague-Dawley male rat
(2) 식이방법 : 정상군에는 10% 지방식이를 섭취시켰으며, 고지방식이군에는 30% 지방식이를 섭취시켰다.(2) Diet: The normal group was fed 10% fat diet, the high-fat diet was fed 30% fat diet.
표 1. 정상식이군과 고지방식이군의 조성Table 1. Composition of normal and high fat diet groups
* : min mix : 종합 미네랄, **: vit mix : 종합 비타민*: min mix: multi-mineral, **: vit mix: multi-vitamin
(3) 실험기간 : 14일(2주)(3) Experiment period: 14 days (2 weeks)
(4) 측정내용(4) Measurement contents
(가) 체중변화 (Body weight gain)(A) Body weight gain
(나) 에너지 섭취량 (Energy intake)(B) Energy intake
(다) 체지방 축적량 (Body fat gain)(C) Body fat gain
(라) 체단백질 축적량 (Body protein gain)(D) Body protein gain
(마) 에너지 소비량 (Energy expenditure)(E) Energy expenditure
(바) 혈장중성지방 함량 (Plasma triglyceride concentratin) (P) Plasma triglyceride concentratin
(사) 혈장 콜레스테롤 함량 (Plasma cholesterol concentration)Plasma cholesterol concentration
이하, 본 발명을 실시예에 의거 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to Examples.
실시예 1Example 1
티백용 분말상의 항비만 녹차의 제조Preparation of Powdered Anti-Obesity Green Tea for Tea Bags
비만억제용 한약재를 아래에 예시한 배합비율(표 2)로 준비하였다. 상엽을제외한 연자육, 동규자, 괴각(槐角), 적하수오, 진호로(陳葫蘆), 초결명, 택사, 대황, 옥수수수염, 산사육(山査肉), 소태나무 등을 각 약재별로 정선하여 각 등분별로 정량한 다음 물로 세척한다. 세척후 동규자, 옥수수수염을 제외한 각 약재들을 혼합하여 압력찜통에 넣고 찌는데 이때 물의 분량은 약재 부피용량의 2정도로 하여 물을 붓고 증숙시킨다. 증숙된 약제들은 대소쿠리에 담아 약제물이 빠지게 한 다음 차건조기용 발에 펴서 식힌다. 동규자는 80℃에서 건조시켜 불기가 약한 덖음솥(가마솥 내부온도 약 100℃)에서 약간만 볶아준다. 세척된 옥수수수염 등은 각각 차건조기용 발에 담고 증숙된 약재들과 함께 80℃로 조정한 차건조기에 넣어 함수량 5%로 건조시킨다. 압력찜통에 약재를 넣고 증숙시킬 때 타지 않도록 주의하며, 증숙 후 대소쿠리에 받아낸 여분의 탕액이 소량이면 그대로 또는 많으면 1/2이상 농축시킨 것을 건조된 약재에 그대로 재흡수시켜 약재의 함수량이 5%이하가 되게 재건조시킨다.Obesity-inhibitory herbs were prepared in the formulation ratio (Table 2) illustrated below. Yeonjak, Donggyuja, crustacean, red sesame, Jinho-ro, ultra-determination, taxa, rhubarb, corn beard, mountain cultivation, and bovine wood except for the upper leaf Measure in equal portions and wash with water. After washing, mix each medicine except Donggyuja and corn beard and put it in a pressure steamer. Steam the water by adding water at 2 volume of medicine and steaming. Steamed medicines are placed in a large colander so that the medicines can be drained and then spread on a foot dryer for cooling. Dongjak is dried at 80 ℃ and roasted only slightly in a hot pot (about 100 ℃ inside cauldron). Washed corn beard, etc., respectively, put in the foot of the car dryer, steamed together with the herbs in the tea dryer adjusted to 80 ℃ dried to 5% water content. Be careful not to burn it when steaming it with steaming medicine in a steamer, and if the amount of excess liquid received in large colander after steaming is small, or if it is large, concentrate it more than 1/2 of it and reabsorb it in the dried medicine as it is. Re-drying to
상엽은 5월 어린엽을 채취하여 물로 세척후 증열시간 45초로 맞춘 찐차용 증열기로 찐 다음 80℃의 차건조기에 넣어 함수량 5%로 건조시켜 아래 표 2의 배합비율에 따라 일정량을 정량한다. 증숙, 건조된 한약재, 볶은 동규자, 옥수수수염, 정량한 상엽 등을 혼합하여 비만억제용 한약재를 얻는다.After harvesting the young leaves in May, washed with water, steamed with steamer steamer set to 45 seconds of steaming time, put into a tea dryer at 80 ℃ and dried to 5% water content to quantify a certain amount according to the mixing ratio of Table 2 below. Steaming, dried herbal medicine, roasted Donggyuja, corn beard, quantified upper leaves, etc. are mixed to obtain an anti-obesity herbal medicine.
표 2. 비만억제용 한약재의 조성과 배합비율 (w/w %)Table 2. Composition and Compounding Ratio of Herbs for Inhibiting Obesity (w / w%)
상기 제 1공정에서 비만억제성 한약재를 건조하여 분쇄기에서 2.0∼1.0㎜의메쉬 크기로 분쇄시켜 비만억제성 한약재 분말을 얻었다.In the first step, the obesity inhibitory herbal medicines were dried and ground to a mesh size of 2.0 to 1.0 mm in a grinder to obtain an obesity inhibitory herbal medicine powder.
이어서, 녹차는 5월 첫물차로 1창 2기 또는 1창 3기의 엽을 채엽한 후 곧 바로 찐차의 첫물차 표준공정을 기준으로 제다하여 함수량 5% 정도의 초제차를 녹차의 재료로 하였다. 상기 녹차를 건조하여 분쇄기에서 2.0 내지 1.0㎜의 메쉬크기로 분쇄시켜 녹차를 분말화하였다. 이와 같은 방법으로 얻어진 녹차와 비만억제성 한약재 분말을 캔음료용의 추출제인 주원료로 사용하고, 또는 상기의 분말들을 일정비율로 혼합하여 티백용의 주원료로 사용한다.Subsequently, green tea was first harvested in May, followed by harvesting the leaves of the first 2nd and 3rd stages, and immediately after the steaming tea was removed based on the standard standard process of the first tea, steamed tea of 5% water content was used as the material of the green tea. The green tea was dried and ground in a grinder to a mesh size of 2.0 to 1.0 mm to powder green tea. Green tea and the anti-obesity herbal medicine powder obtained in this way are used as the main raw material as an extractant for canned beverage, or the powders are mixed at a constant ratio and used as the main raw material for tea bags.
상기에서 얻은 비만억제용 한약재 분말과 녹차 분말을 건조중량비(w/w %) 6:4로 혼합기에 넣어 30∼50분간 잘 혼합함으로써 요구하는 분말 감비차료방을 얻었다.The above-mentioned anti-obesity medicinal herb powder and green tea powder were put in a mixer at a dry weight ratio (w / w%) 6: 4 and mixed well for 30 to 50 minutes, thereby obtaining a powdery gamchabangbang.
현미는 정선·수세한 다음 바로 100℃에서 1시간동안 시루에 쪄서 꼬드밥을 만든 후 건조기용 발에 펴서 건조온도 80℃에서 3∼4시간 정도로 건조시킨 것을 현미의 전처리 과정으로 하였다. 차덖음용 가마솥 온도를 100∼180℃로 하여 전처리된 현미를 타지 않도록 미황색에 도달할 때까지 볶았다. 볶은 현미는 분쇄기에서 메쉬크기를 2.0∼1.0㎜로 분쇄하여 현미 분말을 얻었다. 이와 같이 볶음과 같은 전처리과정을 거친 현미는 구수한 맛이 강해지고 다른 분말성 혼합물과도 잘 섞이는 장점이 있으며, 열수에 대한 풀림성과 침출성이 좋아 티백용 혼합차나 음료용으로 이용하기 좋은 부재료가 될 수 있다.Brown rice was steamed for 1 hour at 100 ° C. immediately after picking and washing, and then sprinkled with rice, then spread on a dryer foot and dried at 80 ° C. for 3 to 4 hours as a pretreatment process of brown rice. The temperature of the cauldron for brewing was set at 100 to 180 ° C., and roasted until it reached light yellow color so as not to burn the pretreated brown rice. Roasted brown rice was pulverized to a mesh size of 2.0 ~ 1.0mm in a grinder to obtain a brown rice powder. Brown rice, which has undergone pre-treatment such as roasting, has a strong taste and blends well with other powdery mixtures.It also has good loosening and leaching properties for hot water, making it a good material for tea bags and beverages. Can be.
상기에서 얻어진 감비차료방 분말과 현미분말을 2:1의 건조중량비로 배합하고 분말성 향료 0.02∼0.06(w/w %)를 첨가하여 혼합기에 넣고 30∼50분간 잘 혼합하였다. 현미와 향료가 잘 혼합된 분말성 감비차료방은 살균과정을 거쳐 요구하는 분말성의 티백용 항비만 녹차를 얻었다.The sensitized tea room powder and brown rice powder obtained above were blended in a dry weight ratio of 2: 1, and powdery flavoring 0.02 to 0.06 (w / w%) was added to the mixer and mixed well for 30 to 50 minutes. Powdered gambichabangbang mixed with brown rice and fragrance was sterilized to obtain the anti-obesity green tea for powdered tea bags.
실시예 2Example 2
캔음료용 액상 항비만 녹차의 제조Preparation of Liquid Anti-Obesity Green Tea for Canned Beverage
실시예 1과 동일한 방법으로 비만억제성 한약재 분말, 녹차분말, 현미분말을 준비하였다. 즉, 비만억제성 한약재 분말과 녹차분말을 건조중량비 6:4로 준비하고 현미분말은 상기 감비차료방(한약재 분말과 녹차 분말)에 대해 건조중량비 2:1로 준비하였다. 다만, 상기 한약재, 녹차 및 현미를 메쉬크기 4.0 내지 2.0㎜로 분쇄하였다.In the same manner as in Example 1, an obesity inhibitory herbal powder, green tea powder, and brown rice powder were prepared. That is, the obesity inhibitory herbal powder and green tea powder were prepared in a dry weight ratio of 6: 4, and the brown rice powder was prepared in a dry weight ratio of 2: 1 for the gambichabangbang (Korean herbal powder and green tea powder). However, the herbal medicine, green tea and brown rice were ground to a mesh size of 4.0 to 2.0mm.
준비된 감비차료방과 현미를 추출할 경우 추출물 총배합량 200g(w/v)을 기준으로 할 경우 추출할 열수의 양은 17∼22ℓ로 한다. 추출방법은 먼저 1차 추출방법으로 혼합직전의 분말상태인 감비차료방의 비만억제성 한약재와 현미를 혼합해 넣고 이온교환수지된 열수 12∼15ℓ를 가하여 100℃에서 20∼30분간(추출양에 따라 조정) 교반추출한 다음 통상의 조건에서 원심분리한 후 여과하였다. 2차 추출도 1차 추출과 동일한 방법으로 하되 추출액의 온도를 75∼85℃의 항온상태로 한 5∼7ℓ의 열수를 가하여 계량된 분말녹차를 넣고 20분간(추출양에 따라 30분간까지 조정) 교반 추출 후 원심분리하여 여과하였다. 1차 추출액과 2차 추출액을 축냉제를 이용하여 20℃ 정도로 냉각시켜 감압여과 장치로 여과한 후 혼합하였다. 혼합된 추출액에 비타민 C 0.02∼0.04%(w/v %), 액상향료 0.02∼0.08%(v/v %) 등을 첨가시키고 평면식열교환기에서 90±5℃로 가열시킨 다음 캔에 뜨거울 때 충전시켰다. 혼합 추출액을 충전시킨 캔의 헤드 스페이스부분에 질소개스를 주입시켜 제품의 용존산소량을 감소시킨 후 뚜껑을 밀봉하였다. 밀봉된 캔을 살균, 냉각시켜 음료용 항비만 녹차를 얻었다.When extracting the prepared fermented tea room and brown rice, the amount of hot water to be extracted is based on the total amount of 200g (w / v) of extract. Extraction method is the first extraction method, mixed with obesity-inhibitory herbal medicine of powdered gambichabang just before mixing, and brown rice, and add 12-15L of hot water of ion-exchange resin and add it for 20-30 minutes at 100 ℃. Adjustment) After stirring and extracting, the mixture was centrifuged under normal conditions and filtered. The second extraction is done in the same way as the first extraction, but the powdered green tea is added for 20 minutes (adjusted to 30 minutes depending on the extraction amount) by adding 5-7 L of hot water with the extraction temperature at 75-85 ℃. After stirring extraction, centrifugation and filtering. The primary and secondary extracts were cooled to about 20 ° C. using a coolant, filtered through a vacuum filter, and mixed. Vitamin C 0.02 ~ 0.04% (w / v%) and liquid fragrance 0.02 ~ 0.08% (v / v%) are added to the mixed extract, heated to 90 ± 5 ℃ in a planar heat exchanger, and then filled in cans. I was. Nitrogen gas was injected into the head space portion of the can filled with the mixed extract to reduce the dissolved oxygen content of the product, and then the lid was sealed. The sealed cans were sterilized and cooled to obtain a beverage anti-obesity green tea.
시험예 1Test Example 1
실시예 1에서 얻어진 녹차, 비만억제용 한약재, 감비차료방 사이의 일반성분 함량, 색도 및 관능평가를 이 분야에 알려진 방법으로 평가하고, 그 결과를 다음의 표 3, 4, 5에 나타냈다.General ingredient content, color and sensory evaluation between the green tea obtained in Example 1, the herbal medicine for inhibiting obesity, gambichachabang was evaluated by a method known in the art, and the results are shown in the following Tables 3, 4 and 5.
표 3. 녹차, 비만억제용 한약재, 감비차료방의 일반성분 함량Table 3. Contents of General Ingredients of Green Tea, Obesity Inhibitory Herb, and Gambi Tea Room
표 4 녹차, 비만억제용 한약재, 감비차료방의 색도검사(분말상태)Table 4 Color test (green powder) of green tea, anti-obesity herbs, and gambichacha
* 색도(Hunter값) : 1. L, a, b값은 색상과 채도를 나타내기 위한 실측치.* Chromaticity (Hunter value): 1. L, a, b values are actual values for indicating color and saturation.
2. b/a:색상 표시. 3.:채도표시.2. b / a: color display. 3. : Saturation display.
표 5. 녹차, 비만억제용 한약재, 감비차료방의 관능평가 결과Table 5. Sensory Evaluation Results of Green Tea, Obesity Inhibitory Herbs, and Gambi Tea Room
* 총점은 종합적인 풍미 50점, 종합적인 맛을 50점으로 합계 100점이 기준.* The total score is based on 50 points for total flavor and 50 points for total taste.
본 발명에 의해 얻어진 감비차료방은 위 대비의 성분, 색도 및 관능평가 결과에서와 같이 녹차나 비만억제용 한약재에만 있는 성분, 색도의 보완과 풍부한 향미가 가미되어 기호성은 향상되었으나 한약냄새가 강하였다.Gambichabang obtained by the present invention, as shown in the components, color and sensory evaluation results of the above contrast, ingredients, color supplements and rich flavors were added only in the green tea or anti-obesity medicinal herbs to improve palatability, but the smell of Chinese medicine was strong .
시험예 2Test Example 2
비만억제성 효과 검색을 위한 동물실험용 고지방 식이군 제조 및 동물 실험방법을 이용하여 비만억제성 효과를 검색하였다. 실험동물 Sprague-Dawley rat를 대상으로 녹차는 75℃ 증류수에서 3분간 추출하였고 비만억제용 한약재의 약재는 끓는 물에서 약 3시간 정도 추출하였다. 추출물은 Whatman filter paper No 41로 여과한 후 냉동건조하여 분말형태로 만들어 졌다. 이렇게 해서 얻은 녹차 및 비만억제용 한약재의 분말형태의 수용성 물질은 고지방 식이에 1% 되게 섞어 투여하였는데 이때 녹차와 비만억제용 한약재의 약재의 비율은 4 : 6 이었다. 실험용 쥐에게 투여한 기간은 14일(2주)이었으며, 측정내용은 체중변화(Body weight gain), 에너지섭취량(Energy intake), 체지방축적량(Body fat gain), 체단백질축적량(Body protein gain), 에너지소비량(Energy expenditure), 혈장중성지방 함량(Plasma triglyceride concentratin), 혈장콜레스테롤 함량(Plasma cholesterol concentration) 등이었다. 통계처리 방법은 실험에서 얻어진 결과의 유의성은 SPSS computer program을 이용하여 분석하였으며 각 결과들은 실험군 별로 평균과 표준오차를 구하였다. 실험군이 두개인 경우에는 unpaired t-test를 행하여 실험군 사이의 평균의 차이에 대한 통계적 유의성을 검증하였다. 그 결과 고지방식이와 정상식이, 고지방식이와 고지방식이+감비차료방에 대한 동물실험 결과는 다음과 같다. 또한, 비교를 위해, 녹차와 단일한약재(소태나무, 동규자)를 고지방식이에 첨가한 경우에 대해서도 동물실험을 하였다.The obesity inhibitory effect was searched by using the high fat diet group for animal experiments and the animal testing method to detect the obesity inhibitory effect. Green tea was extracted from distilled water at 75 ° C for 3 minutes in Sprague-Dawley rats, and herbal medicines for suppressing obesity were extracted from boiling water for about 3 hours. The extract was filtered through Whatman filter paper No 41 and freeze-dried to form a powder. The water-soluble substance in powder form of the green tea and the anti-obesity herbal medicine thus obtained was mixed and administered to a high fat diet at 1%, wherein the ratio of the green tea and the anti-obesity herbal medicine was 4: 6. The duration of administration to the rats was 14 days (2 weeks), and the measurements were body weight gain, energy intake, body fat gain, body protein gain, Energy expenditure, Plasma triglyceride concentratin, Plasma cholesterol concentration. In the statistical processing method, the significance of the results obtained from the experiments was analyzed by using the SPSS computer program, and the results were averaged and standard error for each experimental group. In the case of two experimental groups, unpaired t-test was performed to verify the statistical significance of the difference between the means. As a result, the results of animal experiments on high fat diet and normal diet, high fat diet and high fat diet and fermented tea room are as follows. In addition, for comparison, animal experiments were also conducted for the case of adding green tea and a single herbal medicine (pine wood, Donggyuja) to high fat diet.
표 6에서 정상식이에서 전분의 일부를 라드로 대치하여 지방함유량을 30% 되게한 고지방식이를 14일간 섭취시켰을 때 열량섭취량은 변화하지 않았으나 체지방축적량이 43.5% 증가하였으며 이러한 현상은 에너지소비량 -7.6%로 에너지소비율 감소량에 의한 것으로 유의성이 인정되었다. 그러므로 본 연구에서 사용된 고지방식이는 체지방 축적을 증가시키는데 적합하다.In Table 6, the amount of calories intake was not changed, but body fat accumulation increased by 43.5% after 14 days of high fat diet, which replaced part of starch with lard in the normal diet, and increased fat content by 30%. Significance was found to be due to the decrease in energy consumption in%. Therefore, the high fat diet used in this study is suitable for increasing body fat accumulation.
표 6. 고지방식이와 정상식이에 대한 동물실험 측정 결과Table 6. Results of Animal Experiments on High Fat and Normal Diets
＊p<0.05, vs 고지방 식이군(control)＊ p <0.05, vs high fat diet (control)
※ 증감:[(고지방식이군+감비차료방)/고지방식이군]×100-100 ; 증가(+), 감소(-)※ Increase / Decrease: [(Highland diet group + supervised tea room) / Highland diet group] × 100-100; Increase (+), decrease (-)
표 7에서 감비차료방이 첨가되지 않은 고지방식이군을 대조군으로 하여 감비차료방 1% 첨가한 식이군으로 2주간 동물실험을 수행하였다. 그 결과 대조군에 비해 감비차료방 1%를 첨가한 고지방식이군에서 초기 체중에 비해 최종 체중은 -2.3%, 체중축적량은 -7.3%가 감소하였다. 혈장콜레스테롤 함량은 -7.9%가 감소되었으나 유의성은 없었다. 체내 지방은 -30.8%로 크게 감소함과 동시에 에너지 소비량도 +8.7%가 증가하여 에너지소비율이 큰 것으로 나타나 체중감소와 에너지소비성 사이의 유의성이 5%에서 인정되었다. 이에 비해 체내 중성지방과 단백질은 17.8%와 1.9%로 각각 증가 하여 실험동물의 건강은 양호한 것으로 나타났다.In Table 7, animal experiments were performed for two weeks with the diet group containing 1% Gambangchabang as a control group without the addition of Gambangbangbang. As a result, in the high-fat diet group with 1% Gambangbangbang compared to the control group, the final body weight decreased -2.3% and body weight accumulation -7.3%. Plasma cholesterol content was decreased by -7.9% but was not significant. Body fat decreased to -30.8% and energy consumption increased + 8.7%, indicating a high energy consumption rate. The significance between weight loss and energy consumption was recognized in 5%. In comparison, triglyceride and protein in the body increased to 17.8% and 1.9%, respectively, indicating that the health of experimental animals was good.
표 7. 고지방식이와 고지방식이+ 감비차료방(減肥茶療方)에 대한 동물실험 측정 결과Table 7. Results of Animal Experiments on High Fat and High Fat Diets
＊p<0.05, vs 고지방 식이군(control)＊ p <0.05, vs high fat diet (control)
※효과증감:[(고지방식이군+감비차료방)/고지방식이군]×100-100;증가(+),감소(-)※ Effective increase / decrease: [(high-fat diet + reduction tea room) / high-fat diet group] × 100-100; increase (+), decrease (-)
감비차료방 처리군에서 에너지 섭취량에 영향을 미치지 않으면서 체지방 축적량을 많이 감소시켰는데, 이는 에너지 소비량의 증가에 의한 것으로 즉, 녹차와 한약속에 함유된 카테친과 유용성분 등이 지질의 항산화작용, 체지방 분해 및 체외배출작용, 혈당치 저하작용을 하고, 카페인과 비타민등의 생리적 활성과 상승작용 등이 고혈지저하(高血脂低下)와 체지방의 분해와 감소작용, 지방 화합물 배설작용을 하여, 결국 비만 억제효과가 나타난 것으로 해석된다. 그 결과 체지방의 현격한 감소와 체중저하, 체내의 에너지 소비율 증가, 혈장 콜레스테롤 함량 감소가 고지혈 억제와 체중감소와 같은 비만증 치료효과가 있다는 사실을 입증하였다.In the Gambangchabang treatment group, the body fat accumulation was greatly reduced without affecting the energy intake, which is due to the increase in energy consumption, ie catechins and useful ingredients contained in green tea and Chinese herbal medicines Degradation and excretion of the body, lowering blood sugar levels, physiological activities and synergistic effects of caffeine and vitamins lower hypertension, decompose and reduce body fat, and excretion of fatty compounds, which in turn inhibits obesity The effect is interpreted. As a result, it was proved that a significant reduction in body fat, weight loss, increased energy consumption in the body, and decreased plasma cholesterol content have therapeutic effects on obesity such as suppressing hyperlipidemia and weight loss.
본 발명인 항비만성 녹차는 에너지 소비 촉진이 크고 체지방 감소효과가 커서 근본적인 비만증을 치료하였으며 또한 천연물인 녹차와 한약재가 혼합되어 부작용과 독성이 거의 나타나지 않기 때문에 장기 음용이 가능하고 평상시 음용으로 건강을 해치지 않고 비만을 치료하거나 예방할 수 있다는 점이 일반 비만치료제와는 다르다. 이러한 결과를 토대로 장기 음용시 체지방이 피하조직(皮下組織)에 침적된 경우나 체중이 증가되는 병증, 습관성 비만과 고지혈증뿐 만 아니라 고지혈비대증, 동맥경화 등에도 효능이 있으며, 따라서 비만억제성 차가 혈중지질을 제거하고, 체중을 감소시키는 효과가 있기 때문에 단순비만증과 체질적 비만증의 예방 및 치료에 유용하게 이용될 수 있다.The anti-obesity green tea of the present invention has a large energy promoting effect and a large body fat reduction effect to treat the underlying obesity, and also because the natural green tea and herbal medicines are mixed so that side effects and toxicity are hardly shown, long-term drinking is possible and does not harm the health in normal drinking. It is different from general obesity drugs in that obesity can be treated or prevented. Based on these results, long-term drinking of body fat has subsided to subcutaneous tissues, increased body weight, habitual obesity and hyperlipidemia, as well as hyperlipidemia, arteriosclerosis, etc. Because of the effect of removing lipids and weight loss, it can be usefully used for the prevention and treatment of simple obesity and constitution obesity.
따라서 동물실험을 통한 항비만차의 효능은 녹차의 1차 영양성, 2차 기호성, 3차 생체 조절성 성분과 한약재의 유용성분 등이 상호보완에 의한 유익한 작용으로 나타나 식품으로서의 영양성분과 향과 맛을 즐기는 기호성 부여, 녹차와 한약의 다양한 약리작용으로 나타나는 비만치료와 예방에 대한 효능을 증강시킨 기능성을 겸한 식품으로 국민보건 향상에 크게 기여할 수 있다.Therefore, the efficacy of anti-obesity tea through animal experiments shows that the primary nutrition, secondary palatability, tertiary bioregulatory ingredients and useful ingredients of herbal medicines have beneficial effects by complementary activities. It can contribute greatly to the improvement of national health as it combines functionality with enhanced taste for obesity treatment and prevention, which gives preference to enjoyment and various pharmacological effects of green tea and Chinese medicine.
시험예 3Test Example 3
본 발명품인 티백용 항비만 녹차에 대하여 남, 여 30명에게 오전오후별로 기호평점을 실시하였다. 채점은 9단계기호척도를 사용하였으며, 이것은 "최고로 싫다"의 1점에서 "최고로 좋다"의 9점까지의 점수로 매겼다. 채점결과는 표 8과 같으며 A제품은 향미증진제가 첨가되지 않은 순수한 티백용 항비만 녹차 제품이며 B제품은 향미증진제가 첨가된 티백용 항비만 녹차 제품으로 오전오후별로 채점하여 A, B품을 평점으로 나타내었다.The anti-obesity green tea for tea bags of the present invention was subjected to preference ratings for 30 males and females. Scoring was done using a 9-level symbol scale, which was scored from one point of "I hate the best" to nine points of "best." The scoring results are shown in Table 8. A product is a pure tea bag anti-obesity green tea product without flavor enhancer and B product is a tea bag anti-obesity green tea product with flavor enhancer added. Expressed as a rating.
표 8. 남녀가 오전오후별로 채점한 티백용 항비만녹차 A, B품 평점표Table 8. Score Tables for Anti-Obesity Green Teas for Men and Women
상기 표에 나타난 바와 같이 남녀 모두가 향미증진제를 첨가하지 않은 A제품에 비해 첨가한 B제품에서 향미 기호도가 우수한 것으로 평가되었다.As shown in the above table, both males and females were evaluated to have excellent flavor preference in the added B product compared to the A product without the flavor enhancer.
이와 같은 방법을 실시함으로써 얻어진 티백용 분말성의 항비만 녹차는 감비차료방에 볶은 현미, 향미 증진용 향료가 배합되는 과정을 거치면서 제조된 차는 열수에 침출이 잘되고 볶은 현미와 식용향료의 첨가로 한약의 강한 냄새가 완화되면서 부드럽고 구수한 향미가 증가되어 기능성과 기호성이 우수한 차를 얻을 수 있었다.The powdered anti-obesity green tea for tea bags obtained by carrying out the above-described method is a mixture of roasted brown rice and flavor enhancing fragrance in the tea garden, and the tea produced is well leached in hot water and the Chinese medicine is added by adding roasted brown rice and edible flavoring. As the strong scent of mitigation was alleviated, the soft and delicious flavor was increased to obtain tea with excellent functionality and taste.
시험예 4Test Example 4
본 발명품인 음료용 항비만 녹차에 대하여 남, 여 30명에게 오전오후별로 기호평점을 실시하였다. 채점은 9단계기호척도를 사용하였으며, 이것은 "최고로 싫다"의 1점에서 "최고로 좋다"의 9점까지의 점수로 매겼다. 채점결과는 표 9와 같으며 A제품은 향미증진제가 첨가되지 않은 순수한 캔음료용 항비만 녹차 제품이며 B제품은 향미증진제가 첨가된 캔음료용 항비만 녹차 제품으로 오전오후별로 채점하여 A, B품을 평점으로 나타내었다.The anti-obesity green tea for beverages of the present invention was subjected to preference ratings for 30 males and females. Scoring was done using a 9-level symbol scale, which was scored from one point of "I hate the best" to nine points of "best." The scoring results are shown in Table 9. A product is an anti-obesity green tea product for pure canned beverage without flavor enhancer and B product is an anti-obesity green tea product for canned beverage with flavor enhancer added and scored by morning and afternoon. Width of the body was shown by rating.
표 9. 남녀가 오전오후별로 채점한 캔음료용 항비만 녹차 A, B품 평점표Table 9. Anti-obesity Green Tea A and B Grade Scores for Canned Drinks
상기 표에 나타난 바와 같이 남녀 모두가 향미증진제를 첨가하지 않은 A제품에 비해 첨가한 B제품에서 향미 기호도가 우수한 것으로 평가되었다.As shown in the above table, both males and females were evaluated to have excellent flavor preference in the added B product compared to the A product without the flavor enhancer.
이와 같은 방법으로 실시해 얻어진 캔 음료용 항비만 녹차는 캔음료의 기본재료인 녹차와 한약이 혼합, 가공된 분말상의 감비차료방이어서 저장이 좋고 바로 열수추출이 가능하다. 특히 가공중 열수에서의 침출이 좋고 침출시간이 짧아 공정시간의 단축과 균일한 품질의 음료를 얻을 수 있어 공정상 능율을 향상시켰다. 그리고 가공된 제품은 산화방지와 상승제 역활을 하는 비타민 C성분을 보강하였기 때문에 제품의 저장성, 항산화성, 비만억제성 등이 더욱 강화되어 우수한 비만억제 효과를 기대할 수 있으며, 현미의 구수한 맛과 식용향료의 첨가로 한약의 강한 냄새가 완화되면서 부더럽고 구수한 향미가 증가되어 기능성이 뛰어나고 기호성이 향상된 차를 얻을 수 있다.The anti-obesity green tea for canned beverage obtained by the above-described method is a powdery, non-permanent tea room in which green tea and herbal medicine, which are the basic ingredients of canned beverage, are processed and stored, and thus, hot water extraction is possible. In particular, the leaching in hot water during processing and the leaching time are short, so the process time can be shortened and beverages with uniform quality can be obtained. In addition, since the processed products are reinforced with vitamin C ingredients that act as antioxidants and synergists, the shelf life, anti-oxidation and anti-obesity properties of the products are further enhanced, and excellent anti-obesity effects can be expected. With the addition of fragrance, the strong odor of Chinese medicine is alleviated, and the soft and sweet flavor is increased, resulting in tea with excellent functionality and improved taste.
본 발명의 항비만 녹차는 약리성과 기호성을 겸비하여, 상용차로서 일상적으로 음용할 수 있어, 단순비만자와 현대 성인병의 원인이 되는 체질적인 비만자에게 남녀노소 누구나 비대증, 고지혈증, 고혈지비대증(高血脂肥大症), 고혈압, 관상동맥경화증과 같은 병증을 치료와 예방할 수 있다.The anti-obesity green tea of the present invention combines pharmacology and palatability, and can be routinely consumed as a commercial vehicle. Iii) can treat and prevent conditions such as hypertension and coronary atherosclerosis.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000006766A KR20010081369A (en) | 2000-02-14 | 2000-02-14 | Slimming green tea and method for preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000006766A KR20010081369A (en) | 2000-02-14 | 2000-02-14 | Slimming green tea and method for preparation thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR10-2002-0020422A Division KR100376942B1 (en) | 2002-04-15 | 2002-04-15 | Slimming green tea and method for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010081369A true KR20010081369A (en) | 2001-08-29 |
Family
ID=19646121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020000006766A KR20010081369A (en) | 2000-02-14 | 2000-02-14 | Slimming green tea and method for preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20010081369A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100392775B1 (en) * | 2000-12-18 | 2003-07-23 | 순천시 | Alismatis Rhizoma tea of rosted type and process for prepatration thereof |
| KR100446147B1 (en) * | 2001-09-14 | 2004-08-30 | 이수훈 | The manufacturing method and composition of the health support food utilized by simaroubaceae |
| WO2005051407A1 (en) * | 2003-11-26 | 2005-06-09 | Rexgenebiotech Co., Ltd. | Composition for preventing and treating climacteric symptoms comprising the extract of sophorae fructus |
| US7595080B2 (en) | 2003-10-31 | 2009-09-29 | Rexgenebiotech Co., Ltd. | Method for preparing an extract of fruit of Sophora japonica containing isoflavone |
| CN102860390A (en) * | 2012-08-28 | 2013-01-09 | 杨高林 | Mulberry leaf weight-reducing tea and method for preparing same |
| CN101658220B (en) * | 2008-08-27 | 2013-01-30 | 焦豪然 | Fleece-flower root tea and manufacturing method thereof |
| CN102919416A (en) * | 2012-11-16 | 2013-02-13 | 黑龙江省农垦科学院农畜产品综合利用研究所 | Corn stigma and germinated brown rice tea and preparation method thereof |
-
2000
- 2000-02-14 KR KR1020000006766A patent/KR20010081369A/en not_active IP Right Cessation
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100392775B1 (en) * | 2000-12-18 | 2003-07-23 | 순천시 | Alismatis Rhizoma tea of rosted type and process for prepatration thereof |
| KR100446147B1 (en) * | 2001-09-14 | 2004-08-30 | 이수훈 | The manufacturing method and composition of the health support food utilized by simaroubaceae |
| US7595080B2 (en) | 2003-10-31 | 2009-09-29 | Rexgenebiotech Co., Ltd. | Method for preparing an extract of fruit of Sophora japonica containing isoflavone |
| WO2005051407A1 (en) * | 2003-11-26 | 2005-06-09 | Rexgenebiotech Co., Ltd. | Composition for preventing and treating climacteric symptoms comprising the extract of sophorae fructus |
| CN101658220B (en) * | 2008-08-27 | 2013-01-30 | 焦豪然 | Fleece-flower root tea and manufacturing method thereof |
| CN102860390A (en) * | 2012-08-28 | 2013-01-09 | 杨高林 | Mulberry leaf weight-reducing tea and method for preparing same |
| CN102919416A (en) * | 2012-11-16 | 2013-02-13 | 黑龙江省农垦科学院农畜产品综合利用研究所 | Corn stigma and germinated brown rice tea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103749817A (en) | Jasmine tea and preparation method thereof | |
| US6416807B1 (en) | Mixed fine powder for beverage containing young barley leaves, alfalfa and/or kale | |
| KR100451665B1 (en) | making method of health food, the chief ingredient is carthamus tinctorius seed, and the health food | |
| KR101778101B1 (en) | Method for producing red ginseng dutch coffee for fatigue recovery | |
| KR101166883B1 (en) | Composition of mixed herb medicine for leached tea | |
| KR101140322B1 (en) | Composition of mixed herb medicine for leached tea | |
| KR20110056906A (en) | Composition of mixed herb medicine for leached tea | |
| KR20010081369A (en) | Slimming green tea and method for preparation thereof | |
| KR100376942B1 (en) | Slimming green tea and method for preparation thereof | |
| KR100904083B1 (en) | Manufacture method of hasuo tea-bag and tea-bag thereof | |
| KR20110056908A (en) | Composition of mixed herb medicine for leached tea | |
| KR101083524B1 (en) | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup | |
| KR102104175B1 (en) | Method for producing functional fermented dutch coffee | |
| KR101647917B1 (en) | Chestnut medicinal wine having extract of stachys sieboldii and methods for manufacturing thereof | |
| CN106689523A (en) | Health grinding tea and production technology thereof | |
| JPH11221060A (en) | Drink containing fine powder of hordeum vulgare young leaf and/or medicago sativa l. | |
| KR100376941B1 (en) | Hematic green tea and method for preparation thereof | |
| CN104799370B (en) | A kind of health drink and preparation method thereof | |
| KR970005233B1 (en) | Method for preparing tea | |
| KR100701869B1 (en) | Method for preparing treated gallic and garlic food containing the same | |
| KR20210041387A (en) | A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata | |
| KR20010086193A (en) | Hematic green tea and method for preparation thereof | |
| KR102485019B1 (en) | Functional leached tea and manufacturing method of the same | |
| KR20040094961A (en) | Composition of herb tea powder, coffee powder, greentea powder for anti-obeseness and liquid thereof | |
| CN108378308A (en) | A kind of deer blood double color plate health food and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| A107 | Divisional application of patent | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20120614 Year of fee payment: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20130620 Year of fee payment: 12 |
|
| LAPS | Lapse due to unpaid annual fee |